Among some of AMIA’s suggestions, the association recommended research criteria and clinical care criteria be included in stage 2. AMIA also recommended that the HITPC continue to consider options for Population Health/Public Health Criteria for meaningful use in an ongoing effort to advance quality outcomes and improvements.
AMIA President and CEO Edward H. Shortliffe, MD, said AMIA members are concerned that EHR- and EHR module-testing may fall short of ensuring that HIT systems reliably provide effective cognitive support to users in clinical settings. AMIA members would also like to see systematic testing and evaluation of HIT systems that demonstrate achievement of meaningful use, improved quality of care and interoperability.
Read the news release about AMIA’s position on meaningful use.
Read other coverage about stage 2 meaningful use:
– Professional Associations Release Comments on Stage 2 Meaningful Use
– CHIME to Government: Carefully Assess Stage 1 Before Implementing Stage 2 Meaningful Use
